rabeprazole has been researched along with Dysphagia in 6 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)." | 9.11 | Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005) |
| "In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)." | 5.11 | Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005) |
| "This study aimed to determine whether dysphagia associated with gastroesophageal reflux disease was effectively treated with rabeprazole, a proton pump inhibitor." | 5.11 | Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor. ( Danjo, A; Fujimoto, K; Hara, M; Iwakiri, R; Kikkawa, A; Oda, K; Ootani, A; Sakata, H; Shimoda, R; Tsunada, S; Watanabe, K, 2005) |
| "Symptom-free survival time (in months), dysphagia, and GERD scores." | 2.73 | A randomized, prospective trial of electrosurgical incision followed by rabeprazole versus bougie dilation followed by rabeprazole of symptomatic esophageal (Schatzki's) rings. ( Disario, JA; Fang, JC; Hilden, K; Wills, JC, 2008) |
| "Symptom eradication in patients with Barrett's esophagus (BE) does not guarantee control of acid or duodenogastroesophageal reflux (DGER)." | 1.42 | Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus. ( Bhat, YM; Falk, GW; Maqbool, S; Richter, JE; Vaezi, MF; Yachimski, P, 2015) |
| "Despite consensus recommendations, eosinophilic esophagitis (EoE) is commonly diagnosed upon esophageal eosinophilic infiltration (EEI; based on ≥ 15 eosinophils per high power field; eo/HPF)." | 1.37 | Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. ( Dueñas, C; Fernandez-Bermejo, M; Fernandez-Gonzalez, N; Ferrando-Lamana, L; Gonzalez-Nuñez, MA; Hernandez-Alonso, M; Mateos, JM; Molina-Infante, J; Quintana, EM; Ripoll, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yachimski, P | 1 |
| Maqbool, S | 1 |
| Bhat, YM | 1 |
| Richter, JE | 1 |
| Falk, GW | 1 |
| Vaezi, MF | 1 |
| Minocha, A | 1 |
| Molina-Infante, J | 1 |
| Ferrando-Lamana, L | 1 |
| Ripoll, C | 1 |
| Hernandez-Alonso, M | 1 |
| Mateos, JM | 1 |
| Fernandez-Bermejo, M | 1 |
| Dueñas, C | 1 |
| Fernandez-Gonzalez, N | 1 |
| Quintana, EM | 1 |
| Gonzalez-Nuñez, MA | 1 |
| Archimandritis, AJ | 1 |
| Nikolopoulou, V | 1 |
| Kouklakis, G | 1 |
| Paraskevas, E | 1 |
| Avgerinos, A | 1 |
| Tsianos, E | 1 |
| Triantafillidis, JK | 1 |
| Oda, K | 1 |
| Iwakiri, R | 1 |
| Hara, M | 1 |
| Watanabe, K | 1 |
| Danjo, A | 1 |
| Shimoda, R | 1 |
| Kikkawa, A | 1 |
| Ootani, A | 1 |
| Sakata, H | 1 |
| Tsunada, S | 1 |
| Fujimoto, K | 1 |
| Wills, JC | 1 |
| Hilden, K | 1 |
| Disario, JA | 1 |
| Fang, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)[NCT04149470] | Phase 4 | 90 participants (Anticipated) | Interventional | 2020-10-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for rabeprazole and Dysphagia
| Article | Year |
|---|---|
Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzi | 2005 |
Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition Disord | 2005 |
A randomized, prospective trial of electrosurgical incision followed by rabeprazole versus bougie dilation followed by rabeprazole of symptomatic esophageal (Schatzki's) rings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dila | 2008 |
3 other studies available for rabeprazole and Dysphagia
| Article | Year |
|---|---|
Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus.
Topics: Aged; Barrett Esophagus; Bilirubin; Deglutition Disorders; Esophageal pH Monitoring; Female; Gastroe | 2015 |
Treatment of Schatzki's ring.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Bias; Deglutition Disorders; Dilatation; | 2009 |
Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bi | 2011 |